| Filed On | Filing |
|---|---|
| 21 Mar 2024 |
Form 3: Kozin Marc D, Director
No securities owned |
| 02 Jan 2024 |
Form 3: Decker Lisa Lynn, Director
Holds 0 shares of No securities are beneficially owned |
| 04 Dec 2023 |
Form 3: LaSpaluto Michelle, Chief Financial Officer
Holds 87,939 shares of Common Stock |
| 16 Nov 2023 |
Form 3: Riga Thomas J, COO and CCO
Holds 0 shares of No securities are beneficially owned |
| 30 Mar 2022 |
Form 3: Alrutz Michael Albert, Principal Executive Officer
Holds 119,543 shares of Common Stock |
| 26 Apr 2021 |
Form 3: Vakiener Victoria, Director
Holds 0 shares of No securities are beneficially owned |
| 23 Jun 2020 |
Form 3: Melemed Allen S., Chief Medical Officer
Holds 0 shares of No securities are beneficially owned |
| 25 Feb 2020 |
Form 3: Multani Pratik S, Director
Holds 0 shares of No securities are beneficially owned |
| 06 Aug 2019 |
Form 3: Cantex PHARMACEUTICALS, Inc., 10% owner
Holds 10,000,000 shares of Common Stock, Par Value $0.001 per share |
| 24 Jun 2019 |
Form 3: Jakeman David, Principal Accounting Officer
Holds 20,006 shares of Common Stock |
| 09 Apr 2019 |
Form 3: Sherman Michael A., Director
Holds 0 shares of No securities are beneficially owned |
| 09 Apr 2019 |
Form 3: Andriole Michael T., Chief Business Officer
Holds 0 shares of No securities are beneficially owned |
| 07 Feb 2019 |
Form 3: Alrutz Michael Albert, Principal Executive Officer
Holds 56,645 shares of Common Stock |
| 06 Apr 2018 |
Form 3: Meyer Robert J., Director
No securities owned |
| 06 Apr 2018 |
Form 3: Middleton Fred A, Director
Holds 2,776,093 shares of Common Stock |
| 06 Apr 2018 |
Form 3: Greissing Ed, Director
No securities owned |
| 18 Dec 2014 |
Form 3: Renaud Ronald C Jr, Director
No securities owned |
| 04 Sep 2014 |
Form 3: Nichols Garrett, Chief Medical Officer
No securities owned |
| 24 Jun 2014 |
Form 3: Leonard John M., Director
No securities owned |
| 23 Jun 2014 |
Form 3: Daly James M, Director
No securities owned |
Loading...